Core Insights - Health Catalyst, Inc. reported strong financial performance for the full year 2024, achieving total revenue of 307millionandAdjustedEBITDAof26 million, with expectations for continued growth in 2025 [2][4][11] - The Technology segment generated 195millioninrevenuefor2024,reflectinga1079.6 million, a 6% increase from 75.1millioninQ42023[4]−GrossprofitforQ42024was28.6 million, up 20% from 23.9millioninQ42023,resultinginagrossmarginof3620.7 million, a 32% improvement compared to a net loss of 30.3millioninQ42023[4]KeyMetrics−ThenumberofPlatformClientsincreasedto130in2024,upfrom109in2023[5]−TheDollar−basedRetentionRatefortheTechnologysegmentandTech−EnabledManagedServices(TEMS)was102249.6 million, significantly higher than 106.3millionattheendof2023[17][24]FinancialOutlook−ForQ12025,thecompanyexpectstotalrevenueofapproximately79 million and Adjusted EBITDA of approximately 4million[11]−Forthefullyear2025,totalrevenueisprojectedtobeapproximately335 million, with Technology revenue expected to reach approximately 220millionandAdjustedEBITDAtargetedatapproximately41 million [11]